VivoPower International has announced the commencement of its Stock Buyback Program, authorized by its Board of Directors, with a total budget of up to $5 million for purchasing outstanding shares.

Beam Therapeutics Inc (NASDAQ:BEAM) is one of the best gene therapy stocks to buy in 2026. The stock is up roughly 27% in the past six months and soared more than 60% in the past year. The Street ...

BioRestorative Therapies, Inc. has announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $2 million of its common stock until June 16, 2026.

Performance Stock Unit Programs An expert Q&A on the use of performance stock units (PSUs) in public and private companies, traditional PSU design elements, the primary tax and legal issues related to ...

Charter Communications is hoping to get employees to stay put for longer, sweetening the pot with a new stock purchase plan being offered to tens of thousands of workers. The Stamford, Conn.-based ...

Companies have been feverishly announcing plans to buy back their own stock this year, despite the S&P 500’s 20% surge to record highs and the 1% tax in place on share repurchases. Announced buyback ...

On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...